BofA raised the firm’s price target on Waters (WAT) to $370 from $350 and keeps a Neutral rating on the shares after having hosted CFO Amol Chaubal and other executives for an investor dinner at BofA’s Healthcare Conference. The analyst left the meeting “encouraged,” but reiterates a Neutral rating given the stock’s premium valuation and uncertain market fundamentals.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WAT:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue